Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.
Targeting individuals at highest risk, the lunglife screening programme is designed for people aged 50 to 80, those with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback